Cellosaurus F6D2 (CVCL_B6FG)
Cell line name | F6D2 |
---|---|
Accession | CVCL_B6FG |
Resource Identification Initiative | To cite this cell line use: F6D2 (RRID:CVCL_B6FG) |
Comments | Population: African American. Characteristics: The expression of the beta-galactosidase gene (lacZ) is under the control of a hypoxia-inducible EPO promoter (PubMed=22358881). Doubling time: 45 hours (PubMed=22358881). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00722; Escherichia coli beta-galactosidase (lacZ). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo. Transformant: NCBI_TaxID; 10407; Hepatitis B virus (HBV). Derived from site: In situ; Liver; UBERON=UBERON_0002107. |
Sequence variations | |
Disease | Childhood hepatocellular carcinoma (NCIt: C7955) Pediatric hepatocellular carcinoma (ORDO: Orphanet_33402) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_0326 (Hep 3B2.1-7) |
Sex of cell | Male |
Age at sampling | 8Y |
Category | Cancer cell line |
Publications | PubMed=22358881; DOI=10.1023/A:1007911816292; PMCID=PMC3466759 |
Cross-references | |
Encyclopedic resources | Wikidata; Q111733210 |
Entry history | |
Entry creation | 17-Mar-2022 |
Last entry update | 19-Dec-2024 |
Version number | 6 |